Skip to main content
. Author manuscript; available in PMC: 2018 Jun 22.
Published in final edited form as: Nat Genet. 2017 Dec 22;50(1):42–53. doi: 10.1038/s41588-017-0014-7

Table 3.

Overlap of TAGC asthma-associated SNPs with GWAS catalog association signals by disease group

Disease Group Number of GWAS
catalog association
signals
Number of SNPs
associated with asthma at
Prandom≤10−4 in the multi-
ancestry meta-analysis
P-value for overlap
Cardiovascular 743 20 7.8 × 10−42
Body size and morphology 346 2 5.0 × 10−4
Immune/Autoimmune 480 49 3.0 × 10−129
Nervous system 242 4 1.4 × 10−8
Blood 594 10 1.3 × 10−19
Neuropsychiatric 114 5 1.5 × 10−12
Cancer 417 7 4.0 × 10−14
Endocrine system 276 2 4.0 × 10−4
Digestive system 347 16 1.4 × 10−37
Eyes 177 2 2.0 × 10−4
Respiratory system 85 2 3.6 × 10−5
Infectious disease/Infection 104 2 5.3 × 10−5
Urinary system 144 1 1.5 × 10−2
Alcohol, smoking, and illicit substances 30 0 1
Musculoskeletal system 132 0 1

Overlap of TAGC asthma-associated SNPs with association signals of all diseases/traits in the GWAS catalog3 was investigated for all TAGC SNPs having Prandom≤10−4 in the multi-ancestry meta-analysis; diseases from the GWAS catalog were grouped according to the disease classification proposed by Wang et al.37 (note that the “Digestive system” group includes Crohn's Disease, a subtype of Inflammatory Bowel Disease). The significance of overlap was estimated by the binomial tail probability for observing the shown number of TAGC asthma SNPs among the number of SNPs reported in the GWAS catalog for a group of diseases (for example, the probability of observing 20 or more asthma SNPs with Prandom≤10−4 among the 743 cardiovascular SNPs is shown in the last column); a conservative Bonferroni adjusted significance threshold for enrichment in shared associations is 0.05/15=0.003 (for the 15 disease groups investigated).